المؤلفون: Francisco Borrego, Miguel Genebat, Ane Orrantia, Ezequiel Ruiz-Mateos, Manuel Leal, Joana Vitallé, Leire Gamboa-Urquijo, Laura Tarancon-Diez, Iñigo Terrén, Olatz Zenarruzabeitia

المساهمون: [Vitallé,J, Terrén,I, Gamboa-Urquijo,L, Orrantia,A, Borrego,F, Zenarruzabeitia,O] Biocruces Bizkaia Health Research Institute, Immunopathology Group, Barakaldo, Spain. [Tarancón-Díez,L, Genebat,M, Leal,M, Ruiz-Mateos,E] Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, CSIC, Seville, Spain. [Tarancón-Díez,L] Laboratory of Molecular Immuno-Biology, Gregorio Marañón University Hospital, Health Research Institute, Madrid, Spain. [Leal,M] Internal Medicine Service, Santa Ángela de la Cruz Viamed Hospital, Sevilla, Spain. [Borrego,F] Ikerbasque, Basque Foundation for Science, Bilbao, Spain., This study was supported by a grant from 'Plan Estatal de I+ D+ I 2013–2016, ISCIII-Subdirección de Evaluación y Fomento de la Investigación-Fondo Europeo de Desarrollo Regional (FEDER) (Grant PI13/00889)' and Marie Curie Actions, Career Integration Grant, European Commission (Grant CIG 631674). Joana Vitallé and Iñigo Terrén are recipients of a predoctoral contract funded by the Department of Education, Basque Government (PRE_2017_2_0242 and PRE_2018_1_0032). Joana Vitallé and Iñigo Terrén are recipients of a fellowship from the Jesús de Gangoiti Barrera Foundation (FJGB15/008 and FJGB17/003). Laura Tarancón-Díez was supported by Instituto de Salud Carlos III, PFIS (FI00/00431). Olatz Zenarruzabeitia is recipient of a postdoctoral contract funded by 'Instituto de Salud Carlos III-Contratos Sara Borrell 2017 (CD17/0128)' and the European Social Fund (ESF)-The ESF invests in your future. Ezequiel Ruiz-Mateos is supported by Programa Nicolás Monardes, C0032-2017, Consejería de Salud y Bienestar Social, Junta de Andalucía. Francisco Borrego is an Ikerbasque Research Professor, Ikerbasque, Basque Foundation for Science., Instituto de Salud Carlos III, European Commission, Eusko Jaurlaritza, Fundación Jesús de Gangoiti Barrera, Junta de Andalucía, Ikerbasque Basque Foundation for Science

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)

مصطلحات موضوعية: 0301 basic medicine, Receptor expression, medicine.medical_treatment, T-Lymphocytes, lcsh:Medicine, HIV Infections, CD8-Positive T-Lymphocytes, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, Cytotoxic T cell, Receptors, Immunologic, Receptor, lcsh:Science, Cells, Cultured, Multidisciplinary, medicine.diagnostic_test, CD300a receptor, Degranulation, virus diseases, Citocinas, Linfocitos T, 3. Good health, Cytokine, medicine.anatomical_structure, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], 030220 oncology & carcinogenesis, Cytokines, Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections [Medical Subject Headings], Cell biology, Anti-HIV Agents, T cell, Immunology, Biology, Article, Flow cytometry, 03 medical and health sciences, Antigens, CD, medicine, Humans, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides [Medical Subject Headings], Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 [Medical Subject Headings], Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::Up-Regulation [Medical Subject Headings], lcsh:R, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Intercellular Signaling Peptides and Proteins::Cytokines [Medical Subject Headings], Péptidos, 030104 developmental biology, Anatomy::Cells::Cells, Cultured [Medical Subject Headings], HIV-1, lcsh:Q, Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, CD [Medical Subject Headings], Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::T-Lymphocyte Subsets [Medical Subject Headings], Peptides, CD8, Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes::T-Lymphocytes::CD8-Positive T-Lymphocytes [Medical Subject Headings]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b8b513eec55bddbe8a847bac9d9c4aTest
https://hdl.handle.net/10668/4112Test

المؤلفون: Judd, A, Lodwick, R, Noguera‐Julian, A, Gibb, DM, Butler, K, Costagliola, D, Sabin, C, van Sighem, A, Ledergerber, B, Torti, C, Mocroft, A, Podzamczer, D, Dorrucci, M, De Wit, S, Obel, N, Dabis, F, Cozzi‐Lepri, A, García, F, Brockmeyer, NH, Warszawski, J, Gonzalez‐Tome, MI, Mussini, C, Touloumi, G, Zangerle, R, Ghosn, J, Castagna, A, Fätkenheuer, G, Stephan, C, Meyer, L, Campbell, MA, Chene, G, Phillips, A, Mary Krause, Murielle, Leport, Catherine, Wittkop, Linda, Reiss, Peter, Wit, Ferdinand, Prins, Maria, Bucher, Heiner, Gibb, Diana, Amo, Julia Del, Thorne, Claire, Kirk, Ole, Pérez‐Hoyos, Santiago, Hamouda, Osamah, Bartmeyer, Barbara, Chkhartishvili, Nikoloz, Antinori, Andrea, Monforte, Antonella d'Arminio, Prieto, Luis, Rojo, Pablo, Soriano‐Arandes, Antoni, Battegay, Manuel, Kouyos, Roger, Tookey, Pat, Casabona, Jordi, Miró, Jose M., Konopnick, Deborah, Goetghebuer, Tessa, Sönnerborg, Anders, Teira, Ramon, Garrido, Myriam, Haerry, David, Raben, Dorthe, Chêne, Geneviève, Barger, Diana, Schwimmer, Christine, Termote, Monique, Frederiksen, Casper M., Friis‐Møller, Nina, Kjaer, Jesper, Salbøl Brandt, Rikke, Berenguer, Juan, Bohlius, Julia, Bouteloup, Vincent, Davies, Mary‐Anne, Dunn, David, Egger, Matthias, Furrer, Hansjakob, Guiguet, Marguerite, Grabar, Sophie, Lambotte, Olivier, Leroy, Valériane, Lodi, Sara, Matheron, Sophie, Monge, Susana, Nakagawa, Fumiyo, Paredes, Roger, Puoti, Massimo, Schomaker, Michael, Smit, Colette, Sterne, Jonathan, Thiebaut, Rodolphe, van der Valk, Marc, Wyss, Natasha

المساهمون: The Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, AII - Infectious diseases, APH - Aging & Later Life, Global Health, AII - Amsterdam institute for Infection and Immunity, Infectious diseases, APH - Global Health, Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord., [Judd,A, Gibb,DM] MRC Clinical Trials Unit, University College London, London, UK. [ Lodwick,R, Sabin,C, Mocroft,A, Cozzi-Lepri,A, Phillips,A] Department of Infection and Population Health, University College London, London, UK. [Noguera-Julian,A] Institut de Recerca Pedi atrica Hospital Sant Joan de Deu, Barcelona, Spain. Departament de Pediatria, Universitat de Barcelona, Barcelona, Spain. CIBER de Epidemiologıa y Salud Publica Ciberesp, Barcelona, Spain. [Butler,K] Department of Infectious Diseases and Immunology, Our Lady’s Children’s Hospital, Crumlin, Dublin, Ireland. [Costagliola,D] INSERM, UPMC Univ Paris 06, Institut Pierre Louis d’epidemiologie et de Sante Publique (IPLESP UMRS 1136), Sorbonne Universites, Paris, France. [van Sighem,A] Stichting HIV Monitoring, Amsterdam, The Netherlands. [Ledergerber,B] Division of Infectious Diseases and Hospital Epidemiology, University of Zurich, Zurich, Switzerland. [Torti,C] Unit of Infectious and Tropical Diseases, Department of Medical and Surgical Sciences, University 'Magna Graecia', Catanzaro, Italy. [Podzamczer,D[ HUV and STD Unit, Infectious Diseases Service, Hospital Universitari de Bellvitge. L’Hospitalet, Barcelona, Spain. [Dorrucci,M] Istituto Superiore di Sanit a, Rome, Italy. [De Wit,S] Departement of Infectious Diseases, Centre Hospitalier Saint-Pierre, Universite Libre de Bruxelles, Brussels, Belgium. [Obel,N] Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. [Dabis,F, Chene,D] NSERM U1219 – Centre Inserm Bordeaux Population Health, Universite de Bordeaux, Bordeaux, France. ISPED, Centre INSERM U1219-Bordeaux Population Health, Universite de Bordeaux, Bordeaux, France. [Garcia,F] Clinical Microbiology Department, Complejo Hospitalario Universitario Granada, Instituto de Investigacion Biosanitaria ibs.Granada, Granada, Spain. [Brockmeyer,NH] Department of Dermatology, Venerology and Allergology, Center for Sexual Health and Medicine, St. Josef Hospital, Ruhr-Universität Bochum, Bochum, Germany. [Warszawski,J] INSERM CESP U1018, AP-HP Public Health Department, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre Paris, France. [Gonzalez-Tome,MI] HIV and Paeds Infectious Diseases Department, Hospital 12 de Octubre, Madrid, Spain. [Mussini,C] Infectious Diseases Clinics, University Hospital, Modena, Italy. [Touloumi,G] Department Hygiene, Epidemiology & Medical Statistics, Medical School, National & Kapodistrian University of Athens, Athens, Greece. [Zangerle,R] Medical University Innsbruck, Innsbruck, Austria. [Ghosn,J] EA 7327, Faculté de Médecine site Necker, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. APHP, Unité Fonctionnelle de Thérapeutique en Immuno-Infectiologie, Hôpitaux Universitaires Paris Centre site Hôtel Dieu, Paris, France. [Castagna,A] San Raffaele Scientific Institute, Vita-SaLute University, Milan, Italy. [Fätkenheuer,G] Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. [Stephan,C] Second Medical Department, Infectious Diseases Unit, Goethe-University Hospital, Frankfurt, Germany. [Meyer,L] NSERM CESP U1018, Université Paris-Sud, Université Paris-Saclay, Paris, France. AP-HP Public Health Department, Le Kremlin-Bicêtre, Paris, France. [Campbell,MA] Centre for Health and Infectious Disease Research, University of Copenhagen, Copenhagen, Denmark. [Chene,G]. CHU de Bordeaux, Pole de sante publique, Service d'information medicale, Bordeaux, France., Financial disclosure: The PLATO II project is funded by the UK Medical Research Council (award G0700832). The COHERE study group has received unrestricted funding from: Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS), France, the HIV Monitoring Foundation, The Netherlands, and the Augustinus Foundation, Denmark. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. The group has also received project-specific funding from the UK Medical Research Council and the Swiss Bridge Foundation., Judd, A, Lodwick, R, Noguera-Julian, A, Gibb, D, Butler, K, Costagliola, D, Sabin, C, van Sighem, A, Ledergerber, B, Torti, C, Mocroft, A, Podzamczer, D, Dorrucci, M, De Wit, S, Obel, N, Dabis, F, Cozzi-Lepri, A, García, F, Brockmeyer, N, Warszawski, J, Gonzalez-Tome, M, Mussini, C, Touloumi, G, Zangerle, R, Ghosn, J, Castagna, A, Fätkenheuer, G, Stephan, C, Meyer, L, Campbell, M, Chene, G, Phillips, A, Puoti, M, Goethe-Universität Frankfurt am Main, Sexualité et soins (Genre, Sexualité, Santé) (CESP - INSERM U1018 - Equipe 7), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, University of Copenhagen = Københavns Universitet (UCPH), Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université Bordeaux Segalen - Bordeaux 2, University College of London [London] (UCL), Universitat Autònoma de Barcelona (UAB), Hospital Sant Joan de Déu [Barcelona], CIBER de Epidemiología y Salud Pública (CIBERESP), Our Lady's Children's Hospital Crumlin (OLCHC), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Stichting HIV Monitoring [Amsterdam], Universiteit van Amsterdam (UvA), University hospital of Zurich [Zurich], Università degli Studi 'Magna Graecia' di Catanzaro = University of Catanzaro (UMG), Institut d'Investigació Biomèdica de Bellvitge [Barcelone] (IDIBELL), Istituto Superiore di Sanita [Rome], Université libre de Bruxelles (ULB), Copenhagen University Hospital, Universidad de Granada = University of Granada (UGR), Ruhr-Universität Bochum [Bochum], Hospital Universitario 12 de Octubre [Madrid], Azienda Ospedaleria Universitaria di Modena, National and Kapodistrian University of Athens (NKUA), Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Infection à VIH, réservoirs, diversité génétique et résistance aux antirétroviraux (ARV) (EA 7327), Université Paris Descartes - Paris 5 (UPD5), Hôpital Hôtel-Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie] (UniSR), University Hospital of Cologne [Cologne], HAL-SU, Gestionnaire, The Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in, Eurocoord

المصدر: HIV medicine, 18(3), 171-180. Wiley-Blackwell
HIV Medicine
Judd, A, Lodwick, R, Noguera-Julian, A, Gibb, D M, Butler, K, Costagliola, D, Sabin, C, van Sighem, A, Ledergerber, B, Torti, C, Mocroft, A, Podzamczer, D, Dorrucci, M, De Wit, S, Obel, N, Dabis, F, Cozzi-Lepri, A, García, F, Brockmeyer, N H, Warszawski, J, Gonzalez-Tome, M I, Mussini, C, Touloumi, G, Zangerle, R, Ghosn, J, Castagna, A, Fätkenheuer, G, Stephan, C, Meyer, L, Campbell, M A, Chene, G, Phillips, A & Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 2017, ' Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe ', HIV Medicine, vol. 18, no. 3, pp. 171-180 . https://doi.org/10.1111/hiv.12411Test
HIV medicine, 18 (3
HIV medicine
HIV medicine, 2017, 18 (3), pp.171--180. ⟨10.1111/hiv.12411⟩
HIV MEDICINE
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
The Pursuing Later Treatment Options II (PLATO II) Project Team, Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord & Lodwick, R 2017, ' Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe ', HIV Medicine, vol. 18, no. 3, pp. 171-180 . https://doi.org/10.1111/hiv.12411Test
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

مصطلحات موضوعية: Male, HIV Infections, Pharmacologie, Santé publique, Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Sexual Behavior::Sexuality::Heterosexuality [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, Pharmacology (medical), Inhibidores de proteasas, Young adult, Europe, perinatal HIV infection, virological failure, young people, Adolescent, Adult, Anti-Retroviral Agents, Child, Child, Preschool, Cohort Studies, Female, Humans, Infant, Time Factors, Treatment Failure, Young Adult, Drug Resistance, Viral, Population Groups, Pathologie maladies infectieuses, ComputingMilieux_MISCELLANEOUS, Adolescente, ADN polimerasa dirigida por ADN, Original Research, Health Policy, Enfermedades transmisibles, 3. Good health, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], G0700832, Young people, Viral load, Human, Factores de riesgo, medicine.medical_specialty, 030106 microbiology, HIV Infections/drug therapy, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Reverse Transcriptase Inhibitors [Medical Subject Headings], 03 medical and health sciences, Virological failure, Recién nacido, Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::RNA [Medical Subject Headings], Heterosexualidad, Persons::Persons::Age Groups::Adult [Medical Subject Headings], Diseases::Bacterial Infections and Mycoses::Infection::Communicable Diseases [Medical Subject Headings], Perinatal HIV infection, RCUK, medicine.disease, Infecciones por VIH, Persons::Persons::Age Groups::Infant::Infant, Newborn [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Microbiological Techniques::Viral Load [Medical Subject Headings], Observational study, Geographical Locations::Geographic Locations::Europe [Medical Subject Headings], 0301 basic medicine, Pediatrics, Science et gestion hospitalières, Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Nucleotidyltransferases::DNA Nucleotidyltransferases::DNA-Directed DNA Polymerase [Medical Subject Headings], Diseases::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections [Medical Subject Headings], Anti-Retroviral Agents/therapeutic use, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings], Interquartile range, Epidemiology, HIV Infection, 030212 general & internal medicine, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Adulto, MRC, Infectious Diseases, Niño, Europa, VIH-1, Population Group, Time Factor, Persons::Persons::Age Groups::Adolescent [Medical Subject Headings], Acquired immunodeficiency syndrome (AIDS), medicine, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors [Medical Subject Headings], Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections::Acquired Immunodeficiency Syndrome [Medical Subject Headings], Persons::Persons::Age Groups::Child [Medical Subject Headings], ddc:610, Intervalos de confianza, Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 [Medical Subject Headings], business.industry, Inhibidores de la transcriptasa inversa, Confidence interval, Carga viral, Fármacos anti-VIH, Anti-Retroviral Agent, Cohort Studie, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/octet-stream; application/pdf; application/vnd.oasis.opendocument.text; 1 full-text file(s): application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e760d56b25efa0fc565a6a37138bde9Test
https://doi.org/10.1111/hiv.12411Test

المؤلفون: Eduardo Muñoz, María Ángeles Muñoz-Fernández, Raquel Juárez-Sánchez, Ignacio Relaño-Rodríguez, Carolina Pavicic

المساهمون: [Relaño-Rodríguez,I, Juárez-Sánchez,R, Muñoz-Fernández,MA] Molecular Immunology Laboratory, Hospital General Universitario Gregorio Marañón, Madrid, Spain. [Relaño-Rodríguez,I, Muñoz-Fernández,MA] Health Research Institute Gregorio Marañón (IiSGM), Spanish HIV HGM BioBank, Madrid, Spain.[Relaño-Rodríguez,I, Muñoz-Fernández,MA] Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain. [Relaño-Rodríguez,I, Pavicic,C] Innohealth, Parque Científico de Madrid, Madrid, Spain. [Muñoz,E] Department of Cell Biology, Physiology and Immunology, Instituto Maimónides de Investigaciones Biomédicas de Córdoba (IMIBIC)/Reina Sofia University Hospital University of Córdoba, Córdoba, Spain., This work has been (partially) funded by the RD16/0025/0019, project as part of the project Acción Estratégica en Salud, Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica (2013–2016) and co-financed by the Instituto de Salud Carlos III (Subdirección General de Evaluación) and Fondo Europeo de Desarrollo Regional (FEDER), RETIC PT17/0015/0042, Fondo de Investigacion Sanitaria (FIS) (Grant Number PI16/01863), EPIICAL Project.

المصدر: Journal of Nanobiotechnology, Vol 17, Iss 1, Pp 1-8 (2019)
Journal of Nanobiotechnology

مصطلحات موضوعية: Latency reversal agents, Polymers, Lymphocyte, Pharmaceutical Science, Medicine (miscellaneous), HIV Infections, 02 engineering and technology, Phenomena and Processes::Chemical Phenomena::Physicochemical Phenomena::Surface Properties [Medical Subject Headings], 01 natural sciences, Applied Microbiology and Biotechnology, Monocytes, Romidepsin, Chemicals and Drugs::Organic Chemicals::Lactones::Macrolides::Bryostatins [Medical Subject Headings], Chemicals and Drugs::Polycyclic Compounds::Macrocyclic Compounds::Peptides, Cyclic::Depsipeptides [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], chemistry.chemical_compound, Anatomy::Cells::Cells, Cultured::Cell Line [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Immunologic Factors::Adjuvants, Immunologic [Medical Subject Headings], Depsipeptides, Phenomena and Processes::Chemical Phenomena::Physicochemical Phenomena::Particle Size [Medical Subject Headings], Panobinostat, Lymphocytes, Bryostatin, Latencia del virus, Organisms::Viruses::Vertebrate Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 [Medical Subject Headings], medicine.diagnostic_test, Chemistry, Silanes, 021001 nanoscience & nanotechnology, Bryostatins, Polyelectrolytes, medicine.anatomical_structure, Nanomedicine, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], lcsh:R855-855.5, Nanomedicina, Molecular Medicine, Drug Therapy, Combination, Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections [Medical Subject Headings], 0210 nano-technology, VIH-1, medicine.drug, Dendrimers, lcsh:Medical technology, Anti-HIV Agents, Cell Survival, Surface Properties, Short Communication, lcsh:Biotechnology, Biomedical Engineering, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination [Medical Subject Headings], Bioengineering, Context (language use), 010402 general chemistry, Flow cytometry, Cell Line, Anatomy::Hemic and Immune Systems::Immune System::Mononuclear Phagocyte System::Monocytes [Medical Subject Headings], Adjuvants, Immunologic, lcsh:TP248.13-248.65, Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Survival [Medical Subject Headings], medicine, Humans, Anatomy::Cells::Blood Cells::Leukocytes::Leukocytes, Mononuclear::Lymphocytes [Medical Subject Headings], Particle Size, Monocyte, Dendrímeros, Chemicals and Drugs::Macromolecular Substances::Polymers [Medical Subject Headings], 0104 chemical sciences, Drug Liberation, Cell culture, Cancer research, HIV-1, HIV-1 latency, Chemicals and Drugs::Macromolecular Substances::Polymers::Dendrimers [Medical Subject Headings], Chemicals and Drugs::Organic Chemicals::Organosilicon Compounds::Silanes [Medical Subject Headings]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c851436e8654cf8e68db9f01aebc08baTest
https://hdl.handle.net/10668/3128Test

المؤلفون: Falcon-Neyra, Lola, Palladino, Claudia, Navarro Gómez, María Luisa, Soler-Palacín, Pere, González-Tomé, María Isabel, De Ory, Santiago J, Frick, Marie Antoinette, Fortuny, Clàudia, Noguera-Julian, Antoni, Moreno, Elena Bermúdez, Santos, Juan Luis, Olbrich, Peter, López-Cortés, Luis F, Briz, Verónica, Neth, Olaf, CoRISpe working group

المساهمون: Red de Investigación Cooperativa en Investigación en Sida (España), Instituto de Salud Carlos III, Fundação para a Ciência e a Tecnologia (Portugal), Universitat de Barcelona, Fundação para a Ciência e Tecnologia (Portugal), CoRISpe working group, [Falcon-Neyra,L, Neth,N, Olbrich,A] Unidad de Enfermedades Infecciosas e Inmunopatologias, Hospital Infantil Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Palladino,C] Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal. [Palladino,C, Navarro Gómez,NL] Sección de Enfermedades Infecciosas, Servicio de Pediatría, Hospital General Universitario Gregorio Marañón, Madrid. [Soler-Palacín,P, Frick,MA] Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Hospital Universitari Vall d’Hebron, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona. [González-Tomé,MI] Servicio de Infecciosas Pediátricas, Hospital Universitario Doce de Octubre. [De Ory,SJ] Laboratorio InmunoBiología Molecular, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid. [Fortuny,C, Noguera-Julian,A] Unitat d’Infectologia, Servei de Pediatria, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain. [Bermúdez Moreno,E] Servicio de Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid. [Santos,JL] Unidad de Enfermedades Infecciosas e Inmunodeficiencias, Sección Urgencias de Pediatría, Hospital Universitario Virgen de las Nieves, Granada. [López-Cortés,LF] Enfermedades Infecciosas, Microbiología y Medicina Preventiva. Instituto de Biomedicina de Sevilla/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville. [ Briz,V] Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain., Financial support was provided by the Instituto de Salud Carlos III through the Red Temática de Investigación Cooperativa en Sida (ISCIII-RETIC RD06/006, RD12/0017/0035, and RD12/0017/0037) and FIPSE (grant number: 36-0910-10). This work has been also supported by grants from Instituto de Salud Carlos III (Ref. MPY 1039/14 to VB). CP is supported by the Portuguese Fundação para a Ciência e Tecnologia (FCT) (grant number SFRH/BPD/77448/2011, part of the EDCTP2 program supported by the European Union). VB is supported by the Miguel Servet program run by the Fondo de Investigación Sanitaria (ISCIII) (grant number CP13/00098).

المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: Male, medicine.medical_treatment, HIV Infections, Adolescents, Sida en els infants, Gastroenterology, Pediatrics, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], chemistry.chemical_compound, 0302 clinical medicine, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cell Count::Blood Cell Count::Leukocyte Count::Lymphocyte Count::CD4 Lymphocyte Count [Medical Subject Headings], Emtricitabine, 030212 general & internal medicine, Child, Children, Adolescente, Chemicals and Drugs::Pharmaceutical Preparations::Dosage Forms::Tablets [Medical Subject Headings], Pediatria, Antiretrovirals, Comprimidos, Immunosuppression, Enzyme inhibitors, General Medicine, Antiretroviral therapy, Humanos, 3. Good health, ARN, Combinación emtricitabina, rilpivirina y tenofovir, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], Treatment Outcome, Named Groups::Persons::Age Groups::Adolescent [Medical Subject Headings], Rilpivirine, Lípidos, RNA, Viral, Drug Therapy, Combination, Female, Estudios de seguimiento, VIH-1, Colesterol, Viral load, medicine.drug, medicine.medical_specialty, Adolescent, Anti-HIV Agents, Chemicals and Drugs::Lipids [Medical Subject Headings], 03 medical and health sciences, Pharmacotherapy, Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::RNA [Medical Subject Headings], Internal medicine, AIDS (Disease) in children, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Longitudinal Studies::Follow-Up Studies [Medical Subject Headings], Chemicals and Drugs::Organic Chemicals::Nitriles::Rilpivirine::Emtricitabine, Rilpivirine, Tenofovir Drug Combination [Medical Subject Headings], medicine, VIH (Virus), Humans, Adverse effect, Tenofovir, Retrospective Studies, Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 [Medical Subject Headings], business.industry, HIV (Viruses), Recuento de linfocito CD4, Off-Label Use, Antiretroviral agents, Chemicals and Drugs::Lipids::Sterols::Cholesterol [Medical Subject Headings], Discontinuation, Surgery, Carga viral, Regimen, Fármacos anti-VIH, chemistry, Inhibidors enzimàtics, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Microbiological Techniques::Viral Load [Medical Subject Headings], HIV-1, business, 030217 neurology & neurosurgery, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea56e9eb84d2ac131c42f2911b7eb7b7Test
https://hdl.handle.net/20.500.12530/26161Test

المؤلفون: Doyle, Tomas, Dunn, David T., Ceccherini-Silberstein, Francesca, De Mendoza, Carmen, Garcia, Frederico, Smit, Erasmus, Fearnhill, Esther, Marcelin, Anne-Genevieve, Martinez-Picado, Javier, Kaiser, Rolf, Geretti, Anna Maria

المساهمون: CORONET Study Group, [Doyle,T] Department of Infectious Diseases, King's College London, London, UK. [Dunn,DT, Fearnhill,E] MRC Clinical Trial Unit at UCL, London, UK. [Ceccherini-Silberstein,F] Faculty of Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. [De Mendoza,C] Research Institute and Hospital Puerta de Hierro, Madrid, Spain. [Garcia,F] HU San Cecilio, Granada, Spain. [Smit,E] Heart of England NHS Foundation Trust, Birmingham, UK. [Marcelin,AG] AP-HP, Hôpital Pitié-Salpêtrière, INSERM-Sorbonne Universités, Paris, France. [Martinez-Picado,J] IrsiCaixa, ICREA and UVic-UCC, Barcelona, Spain. [Kaiser,R] Institute of Virology, University of Cologne, Cologne, Germany. [Geretti,AM] Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK., The study was supported by a research award made by Merck to the Royal Free Charitable Trust.

المصدر: Journal of Antimicrobial Chemotherapy

مصطلحات موضوعية: Genotype, Anti-HIV Agents, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Integrase Inhibitors [Medical Subject Headings], Estudios de cohortes, Mutation, Missense, HIV Infections, Integrase Inhibitors, Diseases::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections [Medical Subject Headings], Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV [Medical Subject Headings], Europa (continente), Cohort Studies, Mutación Missense, Raltegravir Potassium, Inhibidores de integrasa, Drug Resistance, Viral, Humans, Original Research, Farmacorresistencia viral, Geographicals::Geographic Locations::Europe [Medical Subject Headings], Infecciones por VIH, Europe, Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation::Mutation, Missense [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], Fármacos anti-VIH, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings], HIV-1, VIH-1, Phenomena and Processes::Microbiological Phenomena::Drug Resistance, Microbial::Drug Resistance, Viral [Medical Subject Headings]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e816ec549855b682d3b4a8a2dcbbf8e4Test
https://hdl.handle.net/10668/2506Test

المؤلفون: Luis F López-Cortés, Pompeyo Viciana, José A Girón-González, Alberto Romero-Palacios, Manuel Márquez-Solero, Maria A Martinez-Perez, Miguel A López-Ruz, Javier de la Torre-Lima, Francisco Téllez-Pérez, Marcial Delgado-Fernández, Milagros Garcia-Lázaro, Fernando Lozano, Mohamed O Mohamed-Balghata, Sociedad Andaluza de Enfermedades Infecciosas

المساهمون: [López-Cortés,LF, Viciana,P] Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain. [Girón-González,JA] Hospital Universitario Puerta del Mar, Cádiz, Spain. [Romero-Palacios,A] Hospital Universitario de Puerto Real, Cádiz, Spain. [Márquez-Solero,M] Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Martinez-Perez,MA] Hospital Universitario San Cecilio, Granada, Spain. [López-Ruz,MA] Hospital Universitario Virgen de las Nieves, Granada, Spain. [Torre-Lima,J de la] Hospital Costa del Sol, Málaga, Spain. [Téllez-Pérez,F] Hospital La Línea, Cádiz, Spain. [Delgado-Fernández,M] Hospital Universitario Carlos Haya, Málaga, Spain. [Garcia-Lázaro,M] Hospital Universitario Reina Sofía, Córdoba, Spain. [Lozano,F] Hospital Universitario de Valme, Sevilla, Spain. [Mohamed-Balghata,MO] Complejo Hospitalario de Jaén, Jaén, Spain. [López-Cortés,LF] Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Universidad de Sevilla. Departamento de Medicina

المصدر: idUS. Depósito de Investigación de la Universidad de Sevilla
instname
PLoS ONE, Vol 9, Iss 5, p e97262 (2014)
PLoS ONE
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)

مصطلحات موضوعية: Etravirina, Viral Diseases, lcsh:Medicine, Etravirine, Salvage therapy, HIV Infections, Kaplan-Meier Estimate, Pharmacology, Estudios Multicéntricos como Asunto, Biochemistry, Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections::HIV Seropositivity [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], chemistry.chemical_compound, Immunodeficiency Viruses, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Clinical Trials as Topic::Multicenter Studies as Topic [Medical Subject Headings], Inhibidores de la Proteasa VIH, Drug Discovery, lcsh:Science, education.field_of_study, Multidisciplinary, Obstetrics and Gynecology, HIV diagnosis and management, Humanos, Pyridazines, Infectious Diseases, Treatment Outcome, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], Medical Microbiology, Viral Pathogens, Inhibidores de Proteasas, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Nucleic Acid Synthesis Inhibitors::Reverse Transcriptase Inhibitors [Medical Subject Headings], RNA, Viral, Reverse Transcriptase Inhibitors, Etravirine Plus, Drug Therapy, Combination, Piridazinas, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyridazines [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors::HIV Protease Inhibitors [Medical Subject Headings], Viral load, Inhibidores de Transcriptasa Inversa, Research Article, Biotechnology, medicine.drug, Gene Expression Regulation, Viral, medicine.medical_specialty, Seropositividad para VIH, Drug Research and Development, Efavirenz, Nevirapine, Endpoint Determination, Urology, Population, Microbiology, Non-nucleoside reverse-transcriptase inhibitors, Internal medicine, Nitriles, medicine, Humans, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors [Medical Subject Headings], Adverse effect, education, Microbial Pathogens, Medicine and health sciences, Salvage Therapy, Genitourinary Infections, business.industry, lcsh:R, Biology and Life Sciences, HIV, Diagnostic medicine, Regimen, Pyrimidines, chemistry, Spain, Fármacos Anti-VIH, NNRTIs, Women's Health, lcsh:Q, Clinical Medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a51061866ee47f5b265adf2dc620236Test
https://hdl.handle.net/10668/1629Test

المؤلفون: Roger Paredes, Alexander Thielen, Miguel Álvarez-Tejado, Federico García, David Dalmau, Lidia Ruiz, Christian Pou, Bonaventura Clotet, Francisco M. Codoñer, Rafael Delgado

المساهمون: [Codoner,FM, Pou,C, Ruiz,E, Clotet,B]Institut de Recerca de la SIDA irsiCaixa-HIVACAT, Badalona, Spain. [Clotet,B, Paredes,R] Unitat VIH, Hospital Universitari Germans Trias I Pujol, Badalona, Spain. [Thielen,A] Max Planck Institute für Informatik, Saarbücken, Germany. [García,F] Hospital San Cecilio, Granada, Spain. [Delgado,R] Hospital 12 de Octubre, Madrid, Spain [Dalmau,D]Hospital Universitari Mutua Terrassa, Terrassa, Spain. [Álvarez-Tejado,M] Roche Diagnostics SL, Sant Cugat del Vallés, Spain

المصدر: PLoS ONE
PLoS ONE; Vol 6
PLoS ONE, Vol 6, Iss 5, p e19461 (2011)

مصطلحات موضوعية: Male, Insuficiencia del Tratamiento, Epidemiology, Pyridines, lcsh:Medicine, Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome::Treatment Failure [Medical Subject Headings], Etravirine, Salvage therapy, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Sequence Analysis::High-Throughput Nucleotide Sequencing [Medical Subject Headings], HIV Infections, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyridines [Medical Subject Headings], Agentes Anti VIH, Secuenciación de Nucleótidos de Alto Rendimiento, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Indinavir, Treatment Failure, lcsh:Science, Masculino, Darunavir, 0303 health sciences, education.field_of_study, Molecular Epidemiology, Sulfonamides, Multidisciplinary, Sulfonamidas, Femenino, High-Throughput Nucleotide Sequencing, Pyrrolidinones, Humanos, 3. Good health, Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Drug Resistance::Drug Resistance, Microbial::Drug Resistance, Viral [Medical Subject Headings], Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation::Mutation, Missense [Medical Subject Headings], Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Sulfones::Sulfonamides [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], Anti-Retroviral Agents, HIV epidemiology, Chemicals and Drugs::Heterocyclic Compounds::Pyrans::Pyrones [Medical Subject Headings], Medicine, Infectious diseases, Diseases::Immune System Diseases::Immunologic Deficiency Syndromes::HIV Infections [Medical Subject Headings], Female, Phenomena and Processes::Genetic Phenomena::Genotype [Medical Subject Headings], VIH-1, Tipranavir, medicine.drug, Research Article, Farmacorresistencia Viral, Genotype, Anti-HIV Agents, Population, Viral diseases, Biology, Pironas, Deep sequencing, Infectious Disease Epidemiology, Terapia Recuperativa, 03 medical and health sciences, Pirrolidinonas, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyrrolidines::Pyrrolidinones [Medical Subject Headings], Piridinas, Raltegravir Potassium, Drug Resistance, Viral, medicine, Humans, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents [Medical Subject Headings], education, 030304 developmental biology, Salvage Therapy, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Salvage Therapy [Medical Subject Headings], Mutación, Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 [Medical Subject Headings], Anatomy::Urogenital System::Genitalia::Genitalia, Female [Medical Subject Headings], 030306 microbiology, lcsh:R, Anatomy::Urogenital System::Genitalia::Genitalia, Male [Medical Subject Headings], HIV, Raltegravir, Virology, Infecciones por VIH, Pyrones, Agentes Antirretrovirales, Mutation, HIV-1, lcsh:Q, Genotipo

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d56131d4e89120c44a97c4154db78bdTest
http://europepmc.org/articles/PMC3094345Test

المؤلفون: Manuel López, Javier de la Torres, Antonio Rivero, María Carmen Gálvez, Fernando Lozano, Rosario Palacios, Jesús Santos, Luis F. López-Cortés, María José Ríos

المساهمون: Grupo andaluz para el estudio de las enfermedades infecciosas (GAEI), [Santos González,JL, Palacios Muñoz,R] Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Lozano,F] Hospital de Valme, Sevilla, Spain. [López,M] Hospital Virgen de las Nieves, Granada, Spain. [Gálvez,MC] Hospital Torrecárdenas, Almería, Spain. [las Torres,J de] Hospital Costa del Sol, Marbella, Spain. [López-Cortés,LF] Hospital Virgen del Rocío, Sevilla, Spain. [Ríos,MJ] Hospital Virgen Macarena, Sevilla, Spain. [Rivero Román,A] Hospital Reina Sofía, Córdoba, Spain.

مصطلحات موضوعية: Cyclopropanes, HIV Infections, Diseases::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], chemistry.chemical_compound, Carga Viral, Antiretroviral naive, Medicine, Didanosine, Adulto, Quimioterapia Combinada, Lamivudine, Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyrimidines::Pyrimidine Nucleosides::Cytidine::Deoxycytidine::Zalcitabine::Lamivudine [Medical Subject Headings], Viral Load, Humanos, Treatment Outcome, Infectious Diseases, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], Alkynes, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Nucleic Acid Synthesis Inhibitors::Reverse Transcriptase Inhibitors [Medical Subject Headings], Toxicity, Cohort, Reverse Transcriptase Inhibitors, Drug Therapy, Combination, VIH-1, Didanosina, Inhibidores de Transcriptasa Inversa, medicine.drug, Adult, medicine.medical_specialty, Efavirenz, Anti-HIV Agents, Resultado del Tratamiento, Immunology, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination [Medical Subject Headings], Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Purines::Purine Nucleosides::Inosine::Didanosine [Medical Subject Headings], Virology, Internal medicine, Humans, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings], Organisms::Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV::HIV-1 [Medical Subject Headings], business.industry, Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Follow-Up Studies [Medical Subject Headings], Infecciones por VIH, Benzoxazines, Regimen, chemistry, Multicenter study, Benzoxazinas, Fármacos Anti-VIH, Estudios de Seguimiento, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Microbiological Techniques::Viral Load [Medical Subject Headings], Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Oxazines::Benzoxazines [Medical Subject Headings], HIV-1, business, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceefec51d93ac884c2fe4a18e46f1a62Test
https://hdl.handle.net/10668/834Test

المؤلفون: Virginia Palomo, Carmen Machado, Felipe Fernández-Cuenca, Ángel Domínguez-Castellano, María J. Ríos-Villegas, Juan Gálvez-Acebal, Miguel A. Muniain, Jesús Rodríguez-Baño

المساهمون: [Machado,C, Ríos-Villegas,MJ, Gálvez-Acebal,J, Domínguez-Castellano,A, Fernández-Cuenca,F, Palomo,V, Muniain,MA, Rodríguez-Baño,J] Infectious Diseases Unit, Hospital Universitario Virgen Macarena. Seville, Spain. [Ríos-Villegas,MJ, Rodríguez-Baño,J] Departament of Medicine, University of Seville, Seville, Spain., The Andalusian Public Foundation for the management of Research in Health of Seville (FISEVI). The Ministry of Science and Innovation, Institute Carlos III of Health - co-financed by European Development Regional Fund 'A way to achieve Europe' ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008)., Universidad de Sevilla. Departamento de Medicina

المصدر: BMC Research Notes, Vol 5, Iss 1, p 578 (2012)
BMC Research Notes
idUS. Depósito de Investigación de la Universidad de Sevilla
instname

مصطلحات موضوعية: Sexually transmitted disease, Male, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies [Medical Subject Headings], lcsh:Medicine, HIV Infections, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Diseases::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections [Medical Subject Headings], Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Antiretroviral Therapy, Highly Active, lcsh:QH301-705.5, Outcome, Medicine(all), Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Schedule [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination::Antiretroviral Therapy, Highly Active [Medical Subject Headings], General Medicine, Middle Aged, Tratamiento antirretrovírico de gran actividad, Antiretroviral therapy, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents [Medical Subject Headings], Treatment Outcome, Cohort, Female, Cohort study, Viral load, Research Article, Adult, medicine.medical_specialty, Anti-HIV Agents, Check Tags::Male [Medical Subject Headings], Treatment interruption, General Biochemistry, Genetics and Molecular Biology, Drug Administration Schedule, Estudios retrospectivos, Internal medicine, medicine, Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], Humans, lcsh:Science (General), Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings], Retrospective Studies, business.industry, Proportional hazards model, Biochemistry, Genetics and Molecular Biology(all), lcsh:R, Pauta de administración medicamentosa, Infecciones por VIH, Surgery, Acute Retroviral Syndrome, Regimen, Fármacos anti-VIH, Check Tags::Female [Medical Subject Headings], lcsh:Biology (General), HIV-1, Resultado del tratamiento, business, lcsh:Q1-390

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::256d00670d2e73f9f7004b26162278abTest